A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy
- PMID: 23164421
- DOI: 10.1016/j.biomaterials.2012.10.072
A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy
Abstract
RNA interference (RNAi) is widely regarded as a promising technology for disease treatment, yet one major obstacle for its clinical application is the lack of efficient siRNA delivery vehicles. In this study, we described a magnetic mesoporous silica nanoparticles (M-MSNs)-based, polyelectrolyte (polyethylenimine, PEI) and fusogenic peptide (KALA)-functionalized siRNA delivery system (denoted as M-MSN_siRNA@PEI-KALA), which was highly effective for initiating target gene silencing both in vitro and in vivo. The construction of this delivery system began with the encapsulation of siRNA within the mesopores of M-MSNs, followed by the coating of PEI on the external surface of siRNA-loaded M-MSNs and the chemical conjugation of KALA peptides. The as-prepared delivery vehicles, with notable siRNA protective effect and negligible cytotoxicity, could be easily internalized into cells, readily escape from the endolysosomes and release the loaded siRNA into the cytoplasm. As a result, the knockdown of enhanced green fluorescent protein (EGFP) and vascular endothelial growth factor (VEGF) in tumor cells were observed, both with excellent RNAi efficiencies. In the following in vivo experiments, the intratumoral injection of M-MSN_VEGF siRNA@PEI-KALA significantly inhibited the tumor growth, possibly by the suppression of neovascularization in tumors. To sum up, we have established a highly effective MSNs-based delivery system, which has great potential to serve as therapeutic siRNA formulation for cancer treatment.
Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier.Biomaterials. 2014 Dec;35(38):10058-69. doi: 10.1016/j.biomaterials.2014.09.003. Epub 2014 Sep 29. Biomaterials. 2014. PMID: 25277774
-
The packaging of siRNA within the mesoporous structure of silica nanoparticles.Biomaterials. 2011 Dec;32(35):9546-56. doi: 10.1016/j.biomaterials.2011.08.068. Epub 2011 Sep 8. Biomaterials. 2011. PMID: 21906804
-
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.J Gene Med. 2010 Mar;12(3):287-300. doi: 10.1002/jgm.1431. J Gene Med. 2010. PMID: 20052738
-
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.Eur J Pharm Biopharm. 2011 Apr;77(3):438-49. doi: 10.1016/j.ejpb.2010.11.007. Epub 2010 Nov 18. Eur J Pharm Biopharm. 2011. PMID: 21093588 Review.
-
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.J Biotechnol. 2006 Jun 25;124(1):12-25. doi: 10.1016/j.jbiotec.2005.12.003. Epub 2006 Jan 18. J Biotechnol. 2006. PMID: 16413079 Review.
Cited by
-
Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy.Molecules. 2021 Apr 19;26(8):2380. doi: 10.3390/molecules26082380. Molecules. 2021. PMID: 33921892 Free PMC article. Review.
-
Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles.Nanomaterials (Basel). 2022 Jun 11;12(12):2016. doi: 10.3390/nano12122016. Nanomaterials (Basel). 2022. PMID: 35745355 Free PMC article.
-
Effects of miR-26a on Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by a Mesoporous Silica Nanoparticle - PEI - Peptide System.Int J Nanomedicine. 2020 Jan 23;15:497-511. doi: 10.2147/IJN.S228797. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32158207 Free PMC article.
-
Surface modification of esophageal stent materials by a polyethylenimine layer aiming at anti-cancer function.J Mater Sci Mater Med. 2017 Aug;28(8):125. doi: 10.1007/s10856-017-5939-y. Epub 2017 Jul 13. J Mater Sci Mater Med. 2017. PMID: 28707137
-
Nanoparticle-based targeted gene therapy for lung cancer.Am J Cancer Res. 2016 May 1;6(5):1118-34. eCollection 2016. Am J Cancer Res. 2016. PMID: 27294004 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous